Research
| S.No | Name | Research | |
|---|---|---|---|
| 1 | Patent published on 15/03/2025 entitled “Subunit Vaccine Development Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis” Application No. 202541023252. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 2 | Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 3 | Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 4 | Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 5 | Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 6 | Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 7 | Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. | |
| 8 | Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. |
Patent published on 15/03/2025 entitled “Subunit Vaccine Development
Targeting Clostridium Botulinum C3 Toxin Based on Structure-Function Dis”
Application No. 202541023252.
Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. Patent published on 28/03/2025 entitled “Exosomal MicroRNA as a Predictive Biomarker for Bleeding Manifestations in Dengue Fever” Application No. 202541024519. Patent published on 18/04/2025 entitled “System and method for screening micrornas to inhibit tumorigenesis in renal clear cell carcinoma through targeted KDR expression regulation” Application No. 202541032218. Patent published on 09/05/2025 entitled “Deciphering Metabolic Regulatory Mechanisms in Vital anarobes for Enhanced Biogas Productions from Proteins Richwaste” Application No. 202541035260. Patent published on 09/05/2025 entitled “System and Method for Structural Constraint-Based evaluation of Immunogenic avirulent Toxins from Clostridium Botulinum C2 And C3 Toxins as Subunit Vaccines” Application No. 202541035274. Patent published on 09/05/2025 entitled “Method for Biofuel Synthesis Via Amino Acid catabolism In Acetoanaerobium Sticklandii Dsm 519” Application No. 202541035354. Patent published on 28/03/2025 entitled “Subunit Vaccine Development Against Human Botulism Evolutionary-Imprint-Based Design from Botulinum Toxin Type A3” Application No. 202541023374. |
Staff Achievements
| S.no | Staff Achievements |
|---|---|
| 1 | S. Rajarajeswari, Brindha Natarajan, R. Subbammal, and B. Roja, Intellectual Property Rights, Ryan Publishers, ISBN: 978-93-48615-86-2. |
| 2 | Successfully completed the Fitness Management course offered by the Consortium for Educational Communication (CEC) through SWAYAM in December 2025. |
| 3 | Attended three days Faculty Development Programme on “Idea Generation Methods” from 12.12.2024 to 14.12.2024 Conducted by ICT Academy at Shrimati Indira Gandhi College, Trichy. |
| 4 | Roja B, Praveenkumar K S, Sasikumar R, Anti-Arthritic Potential of Plant Extracts: A Comprehensive Review of Traditional and Modern Approaches. ISBN 978-93-6126- 655-3. “Innovations and Challenges in Contemporary Agriculture, Science, and Engineering (ICCASE-2024) (Hybrid Mode)”, 07.11.2024-08.11.2024. Conducted by Department of Microbiology, Rathinam College of Arts And Science University in Coimbatore, Tamil Nadu. |
| 5 | Attended one day Seminar on “ICT TOOLS (SERIES-6)”, 04.12.2024. Conducted by Academic Staff College, Dr.M.G.R. Educational and Research Institute. |
| 6 | Attended one day conference on “International Seminar on Advanced Materials for Sustainable Development for Energy Applications”, 09.11.2024.Conducted by Department of Physics, SRM Institute of Science and Technology, Ramapuram Campus, Chennai –600089, Tamil Nadu. |
| 7 | Attended One-Day Workshop on “Real Time - PCR”, 24.10.2024 Conducted by Sri Ramachandra Innovation Incubation Centre, Sri Ramachandra Higher Education and Research, Chennai. |
| 8 | Presented paper in two days International conference on “Innovations and Challenges in Contemporary Agriculture, Science, and Engineering (ICCASE- 2024) (Hybrid Mode)”, 07.11.2024-08.11.2024. Conducted by Department of Microbiology, Rathinam College of Arts And Science University in Coimbatore, Tamil Nadu. |
| 9 | B. Jabeen Bee, P. Gajalakshmi and B. Roja (2024) Evaluation of antibacterial, antioxidant, and anti-inflammatory activities of pigment extracted from dragon fruit peel against Staphylococcus aureus and Escherichia coli. Thanuj International Publishers. ISBN: 978-93-94638-45-7. 208-219. International Conference on “Interdisciplinary Approaches in Biologicsl Sciences for Innovative Research”- ICIBIR-2024 (27.09.2024 (Friday)). Conducted by PG & Research Department of Microbiology & Department of Biotechnology, Shrimati Indira Gandhi College, Trichy. |
| 10 | Attended UGC-RUSA 2.0 Sponsored Two-Day National Seminar Cum Workshop on “Biochar Innovation: Techniques for a Greener Future” from 30.09.2024 to 01.10.2024 Conducted by Department of Environmental Science and Management and Department ofBiotechnology, BharathidasanUniversity,Tiruchirappalli. |
| 11 | B. Roja, R. Prithiviraj, S. Saranya, P. Chellapandi (2024) Functional prediction and assignment of Clostridium botulinum type A1 operome: A quest for prioritizing drug targets.Medicine in Omics: 100040. (23 July 2024). |
| 12 | R. Sasikumar, L. LourduLincy, S. Saranya, B. Roja, L. Thamanna , Anish Sathyan, P. Chellapandi (2024) Field trial evaluation of sensor-based aquaculture automation for improved biofloc shrimp culture. Journal of Water Process Engineering.64: 105661 (July 2024). |